Neonatal Vaccination with an Acellular Pertussis Vaccine Accelerates the Acquisition of Pertussis Antibodies in Infants

This publication has 13 references indexed in Scilit:

• Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life
  Vaccine, 2006
• Potential Strategies to Reduce the Burden of Pertussis
  The Pediatric Infectious Disease Journal, 2005
• Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants
  Vaccine, 2003
• Immunogenicity of a Three-Component Acellular Pertussis Vaccine Administered at Birth
  Pediatrics, 2003
• Delayed immunisation and risk of pertussis in infants: unmatched case-control study
  BMJ, 2003
• Immunogenicity and Protective Efficacy of Neonatal Vaccination against Bordetella pertussis in a Murine Model: Evidence for Early Control of Pertussis
  Infection and Immunity, 2002
• Neonatal and early life vaccinology
  Vaccine, 2001
• Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight months of age
  The Journal of Pediatrics, 1997
• Immunization and Antibody Response in the Newborn Infant
  New England Journal of Medicine, 1965
• Multiple Antigen for Immunization Against Poliomyelitis, Diphtheria, Pertussis, and Tetanus. II. Response of Infants and Young Children to Primary Immunization and Eighteen-Month Booster
  American Journal of Public Health and the Nations Health, 1959